groupH
From EverybodyWiki Bios & Wiki
groupH is an insights and advisory firm working across the pharmaceutical and biotech sectors.
| Private | |
| ISIN | 🆔 |
| Industry | Pharmaceutical Consulting and Market Research |
| Founded 📆 | 2005 |
| Founder 👔 | |
| Headquarters 🏙️ | , , |
Area served 🗺️ | Worldwide |
Key people | Erik Holzinger, Iain Clark, Morris Paterson, Nicolas Touchot, Sara Uttley |
| Members | |
Number of employees | |
| 🌐 Website | grouph |
| 📇 Address | |
| 📞 telephone | |
History
groupH Ltd was set up in April 2005, in London, by Erik Holzinger. In 2016, US operations were set up in San Francisco.
Industry Collaborations
groupH coordinates the EphMRA Online Forecasting Forum. This is a forum for pharma companies and agencies to discuss topics of interest in areas of forecasting and data analysis.
- EphMRA forecasting and data analytics round table discussions 2018
- EphMRA forecasting and data analytics round table discussions 2019
Publications
- Approaches to manage 'affordability' of high-budget impact medicines in key EU countries (2018)[1]
- Early Insights from Commercialization of Gene Therapies in Europe (2017)[2]
- Feasibility and attractiveness of indication value-based pricing in key EU countries (2016)[3]
- The payers' perspective on gene therapies (2015)[4]
- Projecting Market Access Success For Early-Stage Pharma Assets: Getting Past The Hurdles (2013)[5]
- Insomnia (2005) [6]
External Links
Official website https://grouph.com/
References
- ↑ Flume, Mathias; Bardou, Marc; Capri, Stefano; Sola-Morales, Oriol; Cunningham, David; Levin, Lars-Ake; Postma, Maarten J.; Touchot, Nicolas (2018-01-01). "Approaches to manage 'affordability' of high budget impact medicines in key EU countries". Journal of Market Access & Health Policy. 6 (1): 1478539. doi:10.1080/20016689.2018.1478539. PMC 5998770. PMID 29915664.
- ↑ Touchot, Nicolas; Flume, Mathias (February 2017). "Early Insights from Commercialization of Gene Therapies in Europe". Genes. 8 (2): 78. doi:10.3390/genes8020078. PMC 5333067. PMID 28218692.
- ↑ Flume, Mathias; Bardou, Marc; Capri, Stefano; Sola-Morales, Oriol; Cunningham, David; Levin, Lars-Ake; Touchot, Nicolas; Insight, On behalf of Payers’ (2016-01-01). "Feasibility and attractiveness of indication value-based pricing in key EU countries". Journal of Market Access & Health Policy. 4 (1): 30970. doi:10.3402/jmahp.v4.30970. PMC 4864834. PMID 27226845.
- ↑ Touchot, Nicolas; Flume, Mathias (2015-09-08). "The payers' perspective on gene therapies". Nature Biotechnology. 33 (9): 902–904. doi:10.1038/nbt.3332. ISSN 1546-1696. PMID 26348952.
- ↑ "Projecting Market Access Success For Early-Stage Pharma Assets: Getting Past The Hurdles". In Vivo. 2013-02-19. Retrieved 2019-11-11.
- ↑ Holzinger, E. (May 2005). "Insomnia". IDrugs : The Investigational Drugs Journal. 8 (5): 410–415. ISSN 1369-7056. PMID 15883924.
This article "GroupH" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:GroupH. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
